Nutriband CEO Discusses AVERSA(TM) Platform in BioMedWire Podcast
Nutriband CEO Gareth Sheridan discusses the company's AVERSA(TM) platform in The BioMedWire Podcast, offering insights into transdermal drug delivery systems and pain management. Learn how Nutriband aims to improve safety and accessibility in the fentanyl patch market.
This news matters as it sheds light on Nutriband's innovative solution to the opioid crisis in pain management. The development of AVERSA(TM) showcases the company's commitment to addressing the challenges faced by pain patients and the healthcare industry as a whole.